Open access · OA
via Europe PMC
Muscle Aging Heterogeneity: Genetic and Structural Basis of Sarcopenia Resistance.
Titova A, Bilyalov A, Filatov N, Perepechenov S, Kupriyanova D, Brovkin S, Shestakov D, Bodunova N, Gusev O.
Genes · 2025 · ▲ 2 citations
Abstract
Sarcopenia, the progressive loss of skeletal muscle mass and function with age, significantly contributes to frailty and mortality in older adults. Notably, muscles do not age uniformly-some retain structure and strength well into old age. This review explores the mechanisms underlying differential resistance to muscle aging, with a focus on sarcopenia-resistant muscles. We analyzed current literature across molecular biology, genetics, and physiology to identify key regulators of muscle preservation during aging. Special attention was given to muscle fiber types, mitochondrial function, neuromuscular junctions, and satellite cell activity. Muscles dominated by slow-twitch (type I) fibers-such as the soleus, diaphragm, and extraocular muscles-demonstrate enhanced resistance to sarcopenia. This resilience is linked to sustained oxidative metabolism, high mitochondrial density, robust antioxidant defenses, and preserved regenerative capacity. Key molecular pathways include mTOR(definition), PGC-1α, and SIRT1/6, while genetic variants in <i>ACTN3</i>, <i>MSTN</i>, and <i>FOXO3</i> contribute to interindividual differences. In contrast, fast-twitch muscles are more vulnerable due to lower oxidative capacity and satellite cell depletion. Unique innervation patterns and neurotrophic support further protect muscles like extraocular muscles from age-related atrophy. Resistance to sarcopenia is driven by a complex interplay of intrinsic and extrinsic factors. Understanding why specific muscles age more slowly provides insights into muscle resilience and suggests novel strategies for targeted prevention and therapy. Expanding research beyond traditionally studied muscles is essential to develop comprehensive interventions to preserve mobility and independence in aging populations.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/genes16080948
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
A, T., A, B., N, F., S, P., D, K., S, B., D, S., N, B., & O., G. (2025). Muscle Aging Heterogeneity: Genetic and Structural Basis of Sarcopenia Resistance. <em>Genes</em>. https://doi.org/10.3390/genes16080948
Vancouver
A T, A B, N F, S P, D K, S B, et al. Muscle Aging Heterogeneity: Genetic and Structural Basis of Sarcopenia Resistance. Genes. 2025. doi:10.3390/genes16080948.
BibTeX
@article{titova2025Muscle,
title = {Muscle Aging Heterogeneity: Genetic and Structural Basis of Sarcopenia Resistance.},
author = {Titova A and Bilyalov A and Filatov N and Perepechenov S and Kupriyanova D and Brovkin S and Shestakov D and Bodunova N and Gusev O.},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16080948},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Genes 2025
Open access · CC-BY
Muscle Aging Heterogeneity: Genetic and Structural Basis of Sarcopenia Resistance
2019
Open access · OA
The role of SIRT1 in skeletal muscle function and repair of older mice
The FASEB Journal 2013
Citation only
Sarcopenia and hypertrophy in aged skeletal muscle is independent of lifelong muscle stem cell depletion
The Indonesian Biomedical Journal 2015
Open access · CC-BY
Molecular Regulation and Rejuvenation of Muscle Stem (Satellite) Cell Aging
Molecular Therapy 2007
Open access · CC-BY
Antagonism of Myostatin Enhances Muscle Regeneration During Sarcopenia
Clinical cases in mineral and bone metabolism 2014
Preprint · OA